KCT0004024
Not yet recruiting
未知
An investigator's initiated trial to evaluate the safety of cytokine-induced killers during early transplant period of autologous hematopoeitic stem cell transplant recipients
The Catholic University of Korea, Seoul St. Mary's Hospital0 sites32 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- The Catholic University of Korea, Seoul St. Mary's Hospital
- Enrollment
- 32
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Patients between ages 17 and 70 years old
- •2\) Lymphoma patients who are expecting an autologous hematopoeitic stem cell transplantation
- •3\) ECOG performance status 0 or 1
- •4\) Those who are considered to survive longer than 3 months
- •5\) Those without acute infectious disease
- •6\) Those who do not have comorbid tumor
- •7\) Patients who voluntarily signed the informed consent form.
Exclusion Criteria
- •1\) Pregnant women, lactating women, or women who have the possibility of pregnancy or those who have not taken adequate contraceptive measures
- •2\) Sexually active men who do not take proper contraceptive measures
- •3\) Patients with active infection or fever (\=38 ?) with unknown etiology or ongoing bacterial or fungal infections
- •4\) Patients under 19 or over 70 years old
- •5\) ECOG performance status 2, 3, 4
- •6\) Patients with previously proven HIV infection, uncontrolled hypertension (diastolic blood pressure\> 115 mmHg), unstable angina, congestive heart failure (NY class II or higher), poorly controlled severe diabetes, coronary angioplasty within 6 months, Patients with acute myocardial infarction or non\-malignant disease including uncontrolled atrial or ventricular arrhythmia within the past 6 months
- •7\) Patients with mental illness, drug addiction, etc. who are judged to have an influence on the outcome of the study
- •8\) Patients participating in other clinical trials
- •9\) Patients who are judged to be inadequate for a clinical trial by the principal investigator
- •10\) Other serious medical conditions that may reduce compliance with clinical trials
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
An investigator-initiated trial to investigate the utility of LUNAR-1 in colorectal cancer patients with resectable distant metastasespatients scheduled for curative resection for metastasis of colorectal cancerctDNA, colorectal cancer, oligometastasisD015179JPRN-jRCT2072220055Oki Eiji160
Not yet recruiting
Not Applicable
A scientific trail to evaluate the effect of a 13 week long lifestyle change program, anchored in the science of yoga i.e Swasth Wellness Program (SWP), on the systolic blood pressure, in subjects who are not on any anti-hypertensive treatment.CTRI/2021/03/031779Mr Sundeep Kapalia
Active, not recruiting
Not Applicable
The evaluation of safety and efficacy of Sipgeondaebotang in Chronic Fatigue SyndromeKCT0002684Kyung Hee University Oriental Medicine Hospital at Gangdong96
Completed
Phase 1
A Phase 1 Investigator Initiated Study to Evaluate the Safety, Tolerability and Preliminary Effectiveness of AB-SA01 in Patients with Chronic Rhinosinusitis Associated with Staphylococcus aureus InfectioChronic rhinosinusitisInfection - Other infectious diseasesInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12616000002482The Queen Elizabeth Hospital9
Completed
Not Applicable
Investigator initiated clinical trial to validate usefulness of specific system for endoscopic ultrasound guided hepaticogastrostomy (HG01) in malignant biliary obstructioBiliary obstruction due to unresectable malignant tumorsMalignant biliary obstruction, Endoscopic ultrasound, Biliary drainage, HepatocogastrostomyD001660JPRN-jRCT2052210020Kitano Masayuki40